Debunking Vaccine-Autism Myths: CDC Updates Website on Vaccine Safety

Read Debunking Vaccine-Autism Myths: CDC Updates Website on Vaccine Safety on WALY Radio

Debunking Vaccine-Autism Myths: CDC Updates Website on Vaccine Safety

The U.S. Centers for Disease Control and Prevention recently updated its website to state that the claim that vaccines do not cause autism is not evidence-based. This contradicts the previous statement on the website that studies have shown no link between vaccines and autism. The CDC now acknowledges that studies have not ruled out the possibility of a connection between infant vaccines and autism.

Despite the scientific evidence refuting the link between vaccines and autism, prominent figures like U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and President Donald Trump have promoted this theory. The CDC's website still maintains the header "Vaccines do not cause autism" due to an agreement with Senator Bill Cassidy.

The anti-vaccine group Children's Health Defense, previously led by Kennedy, praised the CDC's website changes, stating that the agency is starting to acknowledge the truth about autism. Kennedy has been a vocal advocate for linking vaccines to autism and influencing immunization policies in the country.

Trump has also made unsupported claims linking autism to pregnant women taking pain medication like Tylenol. Autism is a neurological condition characterized by disruptions in brain signaling that affect behavior, communication, interaction, and learning. While the causes of autism remain unclear, rigorous studies have not found any connections between autism and vaccines or medications.

AI technology is revolutionizing the stock market, with Investing.com's ProPicks AI offering winning stock portfolios selected by advanced AI algorithms. Many global portfolios have outperformed their benchmark indexes this year, with the Tech Titans strategy doubling the S&P 500 in 18 months. Notable winners include Super Micro Computer and AppLovin. Investors can leverage AI computing power to identify potential stock market winners.